Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $1.7 Million - $1.82 Million
-54,600 Reduced 53.11%
48,200 $1.6 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $3.18 Million - $3.45 Million
102,800 New
102,800 $3.24 Million
Q3 2019

Nov 12, 2019

SELL
$9.17 - $12.01 $458,500 - $600,500
-50,000 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$10.88 - $17.6 $544,000 - $880,000
50,000 New
50,000 $594,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.